Japanese medical company has agreement to use cancer diagnostics firm’s services

By Eric Strauss, May 26, 2015 at 10:06 AM

A Rutherford-based cancer diagnostics company has been chosen by a Japanese medical firm to provide next-generation gene sequencing services, it announced Monday.

Read more in NJBiz.